ASSOCIATION OF HEPATITIS-C WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA - A CASE STUDY

             Hepatitis-C virus infection (HCV) is endemic in many countries of the world including Georgia. Georgia has a high burden HCV with an estimated 5.4% adult population (1,50,000) people have identified HCV.  According to NCDC (National Centre for Disease Control and Public Health from May 2015 national programme been launched, supported by American company “Gi lead” government Our main goal investigate manage hepatocellular carcinoma. study done patient at Infectious AIDS clinical immunology scientific research centre it found that 57-year-old male who was chronically infected HCV, cirrhosis, directly associated development He diagnosed as chronic hepatitis-C liver cirrhosis (genotype 3a).              Treatment pegylated interferon Ribavirin 1200 mg 6 months continued. Treatment finished without side effects but after RNA detectable or relapsed. In 2015, switched elimination antiviral treatment combined 12 weeks. Sustained viral response developed termination therapy. The alpha-fetoprotein important tumour marker elevated around 583 µ/l. Ultrasound didn’t reveal any lesion MRI scan 3rd grade carcinoma confirmed. Following every month assessed function tests, total bilirubin, complete blood count, ultrasound investigation result enzyme be elevated. It’s crucial (end stage disease) undergo investigations, test further follow up.